Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

bioAffinity Technologies Q1 EPS $(0.21) Down From $(0.18) YoY, Sales $2.41M Up From $921.00 YoY

Author: Benzinga Newsdesk | May 15, 2024 09:28am
bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.21) per share. This is a 16.67 percent decrease over losses of $(0.18) per share from the same period last year. The company reported $2.41 million in sales this quarter. This is a 261.18K percent increase over sales of $921.00 the same period last year.

Posted In: BIAF